1. Home
  2. LSTA vs BOF Comparison

LSTA vs BOF Comparison

Compare LSTA & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • BOF
  • Stock Information
  • Founded
  • LSTA 1980
  • BOF 2017
  • Country
  • LSTA United States
  • BOF United States
  • Employees
  • LSTA N/A
  • BOF N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • BOF Packaged Foods
  • Sector
  • LSTA Health Care
  • BOF Consumer Staples
  • Exchange
  • LSTA Nasdaq
  • BOF Nasdaq
  • Market Cap
  • LSTA 20.0M
  • BOF 16.7M
  • IPO Year
  • LSTA N/A
  • BOF 2023
  • Fundamental
  • Price
  • LSTA $2.39
  • BOF $1.86
  • Analyst Decision
  • LSTA Strong Buy
  • BOF
  • Analyst Count
  • LSTA 1
  • BOF 0
  • Target Price
  • LSTA $15.00
  • BOF N/A
  • AVG Volume (30 Days)
  • LSTA 13.3K
  • BOF 160.1K
  • Earning Date
  • LSTA 05-08-2025
  • BOF 04-14-2025
  • Dividend Yield
  • LSTA N/A
  • BOF N/A
  • EPS Growth
  • LSTA N/A
  • BOF N/A
  • EPS
  • LSTA N/A
  • BOF N/A
  • Revenue
  • LSTA $1,000,000.00
  • BOF $6,516,337.00
  • Revenue This Year
  • LSTA N/A
  • BOF N/A
  • Revenue Next Year
  • LSTA N/A
  • BOF N/A
  • P/E Ratio
  • LSTA N/A
  • BOF N/A
  • Revenue Growth
  • LSTA N/A
  • BOF 130.60
  • 52 Week Low
  • LSTA $1.87
  • BOF $0.61
  • 52 Week High
  • LSTA $4.20
  • BOF $4.11
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 60.67
  • BOF 43.98
  • Support Level
  • LSTA $1.91
  • BOF $1.72
  • Resistance Level
  • LSTA $2.09
  • BOF $1.95
  • Average True Range (ATR)
  • LSTA 0.18
  • BOF 0.21
  • MACD
  • LSTA 0.06
  • BOF -0.03
  • Stochastic Oscillator
  • LSTA 100.00
  • BOF 30.64

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.

Share on Social Networks: